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Abstract: Selaginella species are known to have antimicrobial, antioxidant, anti-inflammatory, anti-
diabetic as well as anticancer effects. However, no study has examined the cytotoxic and anti-
metastatic efficacy of Selaginella repanda (S. repanda) to date. Therefore, this study aimed to evaluate
the potential anti-metastatic properties of ethanol crude extract of S. repanda in human non-small-cell
lung (A-549) and colorectal cancer (HCT-116) cells with possible mechanisms. Effect of S. repanda
crude extract on the growth, adhesion, migration and invasion of the A-549 and HCT-116 were
investigated. We demonstrated that S. repanda crude extract inhibited cell growth of metastatic cells
in a dose and time dependent manner. Incubation of A-549 and HCT-116 cells with 100–500 µg/mL of
S. repanda crude extract significantly inhibited cell adhesion to gelatin coated surface. In the migration
and invasion assay, S. repanda crude extract also significantly inhibited cellular migration and invasion
in both A-549 and HCT-116 cells. Moreover, reverse transcription-polymerase chain reaction, and real-
time PCR (RT-PCR) analysis revealed that the activity and mRNA level of matrix metalloproteinase-9
(MMP-9), matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-
MMP) were inhibited. While the activity of tissue inhibitor matrix metalloproteinase 1 (TIMP-1); an
inhibitor of MMPs was stimulated by S. repanda crude extract in a concentration-dependent manner.
Therefore, the present study not only indicated the inhibition of motility and invasion of malignant
cells by S. repanda, but also revealed that such effects were likely associated with the decrease in
MMP-2/-9 expression of both A-549 and HCT-116 cells. This further suggests that S. repanda could be
used as a potential source of anti-metastasis agent in pharmaceutical development for cancer therapy.
Keywords: Selaginella repanda; non-small cell lung cancer; colorectal cancer; matrix metalloproteins;
tissue inhibitor matrix metalloproteinase; metastasis; gene expression
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1. Introduction
Over the past few years, cancer is the leading cause of death globally, resulting in
about 9.6 million deaths in 2018. In men, commonly occurring cancers are lung, prostate,
colorectal, stomach and liver, whereas, in women, cervical, lung, colorectal and thyroid
cancers are most common [1]. Metastasis is the most devastating hallmark of cancer with
more than 90% of deaths worldwide and a major obstacle in the treatment of cancers, which
is defined as the emergence of secondary and tertiary tumors in tissues and organs aside
from the origin [2,3]. Options available for the treatment of various types of cancers are
chemotherapy, radiation therapy and surgery. All of these treatment options have harmful
and severe adverse effects [4,5]. Therefore, in recent times, back to nature approach is
highly accepted. A large number of plant-based molecules are developed and approved
for anticancer and anti-metastatic therapies [6,7]. Hence, to find out the feasible course
of action to have safe and to lower the adverse effects prompted by chemotherapy, the
continuous exploration for anticancer phytochemicals plays a critical role.
The cosmopolitan genus Selaginella P. Beauv. also acknowledged as a “spike moss”
belongs to the family Selaginellaceae, possessing about 700 to 750 species distributed around
the globe. The Selaginella plants are usually used by a tribal community to cure sore
throat, hepatic disorders, fever, cirrhosis, jaundice, cholecystitis, cough of lungs, diarrhea
and various other related ailments. Moreover, it is also used for promoting the blood
circulation, removing blood stasis, prevention of external bleeding after separation of the
umbilical cord and trauma [8,9]. This is due to the presence of high content of different
phytochemicals including, carbohydrates, chromones, benzenoids, alkaloids, coumarins,
lignans, flavonoids, phenylpropanoids, steroids, pigments and quinoids [10–19]. Although
the members of Selaginella are reported for their efficient medicinal applications, the cy-
totoxicity and anti-metastatic activity of S. repanda (Desv. &Poir.) against lung and colon
cancers have not been described. Furthermore, matrix metalloproteinases (MMPs) are
believed to be intricated in cancer development and progression. MMPs are known to
play a vital role in tumor metastasis, angiogenesis and invasion, and are considered as a
potential anticancer target. Therefore, the present study aimed to find out the cytotoxic
and anti-metastatic efficacy of traditionally treasured plant S. repanda on human non-small
cell lung and colorectal cancer with possible mechanisms explaining the expression of
MMP-2/-9, MT1-MMP and TIMP-1 with and without treatment with S. repanda.
2. Results
2.1. High Resolution-Liquid Chromatography-Mass Spectroscopy (HR-LC-MS) Identification of
S. repanda Phytoconstituents
Comprehensive phytoconstituent analysis from crude extract of S. repanda was carried
out to analyze the plant’s total extract obtained from 85% aqueous ethanol obtained from
the whole plant of S. repanda via UHPLC-PDA-ESI-MS/MS. A diverse class of bioactive
compounds was revealed, which are known to be potent and linked to various biological
activities. Table 1 listed the identified phytoconstituents in S. repanda crude extract and
are in agreement with previous studies [20,21]. A total of fifty-four constituents were
tentatively identified. The molecular mass, mass spectral fragmentation patterns of the
constituents, and standard samples were used for the purpose. Out of all the identified
compounds, phenols and flavonoids were the major constituents. Identified phenols were
isoferulic acid, chlorogenic acid, 4-coumaric acid, 7-hydroxycoumarine, coumarin, caffeic
acid, formononetin, 4-methoxycinnamic acid and 2-amino-1,3,4-octadecanetriol. Identified
potent flavonoid compounds were glycitin, vitexin, rhamnetin, kaempferol, luteolin, rutin,
diosmetin, apigenin H, genistein. Identified potent terpenoids, alkaloids, benzenoids,
monocarboxylic acid and ester compounds were urocanic acid, guvacoline, hordenine,
sedanolide, scopoletin, norharman, citral, methylcinnamate, 8-hydroxyquinoline, pulegone
and 4-hydroxyphenylacetic acid [9].
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Table 1. Phytochemical composition of S. repanda crude extract identified by HR-LC-MS technique [9].
Phytocompounds Formula Class m/z RT (min) Mass
Urocanic acid C6H6N2O2 monocarboxylic acid 131.2 24.845 138.04267
Hordenine C10H15NO alkaloid 167.2 23.071 169.23958
Oleamide C18H35NO fatty acid 286.1 20.177 281.27135
Hexadecanamide C16H33NO fatty acid amide 250.4 19.849 255.25575
Arachidonic acid C20H32O2 polyunsaturated fatty acid 301.8 18.601 304.2397
4-Coumaric acid C9H8O3 phenol 168.2 18.265 164.04718
2-Arachidonoyl glycerol C23H38O4 fatty acid derivative 371.0 16.012 378.27635
Valine C5H11NO2 amino acid 118.4 13.901 117.07901
Genistein C15H10O5 isoflavone 275.3 13.542 270.05214
Diosmetin C16H12O6 flavonoid 294.3 13.534 300.06279
2-Amino-1,3,4-octadecanetriol C18H39NO3 phenol 311.5 13.499 317.29231
Glycitein C16H12O5 flavonoid 288.9 13.477 284.06807
Rhamnetin C16H12O7 flavonoid 311.2 12.452 316.05766
Formononetin C16H12O4 phenol 265.3 12.157 268.07329
Luteolin C15H10O6 flavonoid 278.6 11.735 286.04723
Apigenin C15H10O5 flavone 272.4 11.177 270.05235
Glycitin C22H22O10 isoflavone 442.2 11.088 446.12065
(-)-Caryophyllene oxide C15H24O epoxide 228.4 10.861 220.18227
Kuromanin C21H20O11 pigment 458.1 8.976 448.09996
Kaempferol C15H10O6 flavonoid 294.6 8.662 286.04726
Sedanolide C12H18O2 isobenzofuran 199.5 8.578 194.13039
α-Pinene-2-oxide C10H16O terpenoid 148.9 8.494 152.11989
Quercetin-3β-D-glucoside C21H20O12 flavonoid 260.3 8.438 464.09465
Quercetin C15H10O7 flavonoid 308.6 8.414 302.04192
Vitexin C21H20O10 flavonoid 436.8 8.319 432.10497
Rutin C27H30O16 flavonoid 615.4 8.291 610.15239
4-Methoxycinnamic acid C10H10O3 phenol 186.2 7.754 178.06275
Norharman C11H8N2 alkaloid 164.7 6.725 168.06847
4-Hydroxycoumarin C9H6O3 benzopyrone 158.8 6.568 162.0314
Methyl cinnamate C10H10O2 cinnamic acid ester 164.5 6.458 162.06775
Isoferulic acid C10H10O4 phenol 198.6 6.367 194.05762
Scopoletin C10H8O4 coumarin 196.3 5.969 192.04198
Citral C10H16O terpenoid 145.8 5.575 152.11989
Pulegone C10H16O terpenoid 158.9 4.94 152.11989
Caffeic acid C9H8O4 phenol 186.2 4.692 180.04181
7-Hydroxycoumarine C9H6O3 phenol 169.4 4.651 162.0314
Chlorogenic acid C16H18O9 phenol 360.5 4.646 354.09435
Kynurenic acid C10H7NO3 quinoline carboxylic acid 181.7 3.823 189.04239
Coumarin C9H6O2 phenol 148.6 3.784 146.0365
3-Methylcrotonylglycine C7H11NO3 amino acid 152.6 3.325 157.0737
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Table 1. Cont.
Phytocompounds Formula Class m/z RT (min) Mass
4-Hydroxyphenylacetic acid C8H8O3 benzenoid 156.3 3.314 152.04714
8-Hydroxyquinoline C9H7NO alkaloid 153.2 2.965 145.05255
Maltol C6H6O3 sugar 130.4 2.278 126.03161
Guvacoline C7H11NO2 pyridine alkaloid 145.2 1.539 141.07878
L-Phenylalanine C9H11NO2 amino acid 164.2 1.375 165.07883
L-Norleucine C6H13NO2 amino acid 136.5 1.134 131.09453
L-Pyroglutamic acid C5H7NO3 amino acid 133.1 1.04 129.0425
D-Glucosamine C6 H13 NO5 amino sugar 183.3 0.946 179.079
Betaine C5H11NO2 amino acid 122.2 0.935 117.07901
L(-)-Carnitine C7H15NO3 amino acid derivative 157.6 0.93 161.10489
Acetylcholine C7H15 NO2 essential nutrient (vitamin) 149.7 0.850 145.11
α-Lactose C12H22O11 sugar 349.9 0.839 342.11521
Choline C5H13N O essential nutrient (vitamin) 111.4 0.798 103.09988
Overall, LC-MS analysis endorsed the rich nature of the S. repanda plant in terms of
varying chemical classes of compounds present in it, whereby the majority of all the identi-
fied compounds are flavonoids and phenolics in nature as previously described [9,20,21].
Flavonoids and natural phenolic acids are one of the most prevalent and pharmacologically
active groups of plant secondary metabolites. Whereas, alkaloids are nitrogenous com-
pounds that are widely distributed from prokaryotes to eukaryotes and are well-known for
their different biological activities like anti-microbial, anti-HIV, anticancer and antiparasitic.
These compounds play a crucial role in the prevention of cancer via various mechanisms at
a molecular level. This may include impeding the signaling pathways, migration, differen-
tiation and proliferation inhibition, gene regulation, carcinogen metabolism, induction of
apoptosis via arresting cell cycle, etc. [22,23]. Therefore, the presence of diverse biologically
active constituents contributed immensely to the plant’s bioactive potential, and perhaps
the ensuing better anticancer and anti-metastatic bioactivities.
2.2. Cytotoxic Effect of S. repanda Crude Extract
Cytotoxicity of S. repanda crude extract was evaluated against A549 and HCT-116
cancer cell lines by MTT assay at 24 and 48 h. Significant inhibition of both cancer cells’
viability was observed in a time and dose-dependent manner. The IC50 values for 24 h
were found to be 341.1 µg/mL and 378.8 µg/mL (Figure 1C) and for 48 h were found to be
326.7 µg/mL and 351.4 µg/mL for A549 and HCT-116 cells (Figure 1D).
2.3. Anti-Migratory Effect of S. repanda Crude Extract
The most important metastatic event is the motility of cells, which takes place in
different epithelial cells during the progression of cancer. Wound closure assay was carried
out to study the effect of S. repanda crude extract on the migration of cells over wound
scratch, made on culture plates. The migration of both A549 and HCT-116 cancer cells
was evidently inhibited by the treatment of S. repanda crude extract in a time as well as
dose-dependent manner, when compared to untreated control cells. Hence, S. repanda
crude extract evidently inhibited the anchorage and spread of both cell lines along the edge
of wound scratch (Figure 2A,B).
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2.4. Anti-Invasion Effect of S. repanda Crude Extract
Transwell® cell culture inserts coated with Matrigel matrix were used to evaluate
the ability of S. repanda crude extract to inhibit the invasion of A549 and HCT-116 cells,
following treatment with different concentrations (100–500 µg/mL). The cellular invasion
of both A549 a d HCT-116 cancer cells was significantly inhibited by the treatment of
S. repanda crude extract (100 µg/mL) in a time as well as dose-dependent manner, when
compar d to u tr ated control cells (Figure 2 C).
2.5. Anti-Adhesion Effect of S. repanda Crude Extract
Adhesion to endothelial cells by malignant cells is known to be mediated by extracel-
lular matrix proteins (ECM), thereby, w evaluated the adhesion property of both A549
and HCT-116 cancer cells to gelatin coated surfaces both in the presence and absence of
S. repanda crude extract. The adhesion of A549 and HCT-116 cells were reduced by 75.67%
and 72.0% (500 µg/mL) at the incubation of 6 h. Relative adherence was measured by
setting the number of adherent cells at 6 h to 100% (Figure 3A,B).
Plants 2021, 10, 979 6 of 18




Figure 2. Anti-migration and anti-invasion effects of S. repanda crude extract. (A) Anti-migration 
activity on A-549 cancer cells (B) Anti-migration activity on HCT-116 cancer cells. The number of 
migrated cells was quantified in five different fields from three independent experiments. (C) Anti- 
invasion activity on A-549 and HCT-116 cancer cells. The invading cells were counted in five ran-
dom fields under microscopes. Error bars indicate SDs (± standard deviation) of three independent 
experiments. Significance; ns > 0.05, * p < 0.05, ** p < 0.005, *** p < 0.0005. 
  
Figure 2. Anti-migration and anti-invasion effects of S. repanda crude extract. (A) Anti-migration activity on A-549 cancer
cells (B) Anti-migrati activity o HCT-116 cancer cells. The umber of migrated cells was quantified in five different fields
from three indepen ent experiments. (C) Anti- invasio activity n A-549 and HCT-116 cancer cell The i vading cells
were counted in five random fields under microscopes. Error bars indicate SDs (± standard deviation) of three independent
experiments. Significance; ns > 0.05, * p < 0.05, ** p < 0.005, *** p < 0.0005.
Plants 2021, 10, 979 7 of 18
Plants 2021, 10, x FOR PEER REVIEW 7 of 19 
 
 
2.5. Anti-Adhesion Effect of S. repanda Crude Extract 
Adhesion to endothelial cells by malignant cells is known to be mediated by extra-
cellular matrix proteins (ECM), thereby, we evaluated the adhesion property of both A549 
and HCT-116 cancer cells to gelatin coated surfaces both in the presence and absence of S. 
repanda crude extract. The adhesion of A549 and HCT-116 cells were reduced by 75.67% 
and 72.0% (500 µg/mL) at the incubation of 6 h. Relative adherence was measured by set-
ting the number of adherent cells at 6 h to 100% (Figure 3A,B).  
 
Figure 3. Anti-adhesion effects of S. repanda crude extract on gelatin coated surfaces. (A) Anti-adhe-
sion activity on A-549 cancer cells. (B) Anti-adhesion activity on HCT-116 cancer cells. Error bars 
indicate SDs (± standard deviation) of three independent experiments. Significance; ns > 0.05, * p < 
0.05, ** p < 0.005, *** p < 0.0005. 
2.6. Changes in Transcriptional Level of Metastasis Related Genes  
The expression level of metastasis related genes MMP-2, MMP-9, MT1-MMP and 
TIMP-1 in both A549 and HCT-116 malignant cells, which were induced by S. repanda 
crude extract were determined by real time PCR. Firstly, the expression level of MMP-2 
and MMP-9 genes were evaluated and was found to be decreased in both cells treated 
with S. repanda crude extract after 24 h incubation, when compared to untreated cells (Fig-
ure 4A–D). After the analysis of MMP-2 and MMP-9, we further examined the effect of S. 
repanda crude extract on the expression of activator and inhibitor genes of MMPs (MT1-
MMP and TIMP-1). The expression level of TIMP-1 was found to be increased and of MT1-
MMP gene was decreased in both cells after the treatment of S. repanda crude extract, when 
Figure 3. Anti-adhesion effects of S. repanda crude extract on gelatin coated surfaces. (A) Anti-adhesion activity on A-549
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2.6. Changes in Transcriptional Level of Metastasis Related Genes
The expression level of metastasis related genes MMP-2, MMP-9, MT1-MMP and
TIMP-1 in both A549 and HCT-116 malignant cells, which were induced by S. repanda
crude extract were determined by real time PCR. Firstly, the expression level of MMP-2
and MMP-9 genes were evaluated and was found to be decreased in both cells treated
with S. repanda crude extract after 24 h incubation, when compared to untreated cells
(Figure 4A–D). After the analysis of MMP-2 and MMP-9, we further examined the effect
of S. repanda crude extract on the expression of activator and inhibitor genes of MMPs
(MT1-MMP nd TIMP-1). The expression lev l of TIMP-1 was fou d to be increased and of
MT1-MMP gene was decreased in both cells after the treatment of S. repanda crude extract,
when compared to untreated cells after 24 h incubation (Figure 5A,B). These results show
that S. repanda crude extract can regulate the expression of MMP-2 and MMP-9 genes,
which can possibly further control the cascade of metastasis.
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3. Discussion
Regardless of all current progress in oncology, cancer is still one of the most life-
threatening diseases around the globe [1]. It takes place as a localized disease, but can
extend to different sites of the human body through migration, invasion and metastasis [2].
Metastasis is a multifaceted process involving an array of complicated mechanisms, which
begins with extrication, accumulation and motility of cancer cells, followed by sticking to
endothelial cells and the start of cancerous growth at different sites [24]. Progression of
metastasis occurs after the degradation of ECM with cancer cells via different proteases
like serine proteinase, cathepsins, MMPs and plasminogen activator, which prompts the
separation of the intercellular matrix to promote the mobility of cancer cells [25]. Amongst
involved proteases, MMP-9 and MMP-2 are profoundly implicated in cancer invasion and
metastasis as they are the most essential for the degradation of base membranes [26–28].
Due to resistance to apoptosis and cytotoxic agents, metastasis is the dominant basis
for cancer associated death. The percentage of morbidity and mortality in metastatic
cancer patients is high, due to the failure of current chemotherapy agents to selectively and
effectively kill cancer cells without destroying healthy cells at the sites of metastasis [29].
Metastasis is still a crucial clinical challenge in cancer treatment for researchers around
the globe. Up till now, no such strong cleanse for cancer and its other catastrophic pre-
sentations have been found [29]. Currently, radiation therapy, chemotherapy, surgery are
the conventional treatments for cancer. These treatments come with a range of side effects
to human health; therefore, the importance of traditional medicines may decline. Thus,
metastasis found the greatest challenging obstacle for successful cancer management and
can be viewed as the last edge of cancer research [24].
Since ancient times, natural products have been recognized as an excellent source
of bioactive compounds. They have been the primary source of general medicines, and
can also be used directly as medicines [30–35]. Therefore, the pursuit and curiosity in the
identification of medicinal plants and their derived natural products for evolving the novel
cancer therapeutic strategies expanded vastly in recent times. In our previous study [9], a
comprehensive phytochemical analysis from the crude extract of S. repanda was carried
out via HR-LC-MS. A chromatogram was obtained with both positive and negative run
and different types of phytochemicals were identified. In-depth profiling revealed various
classes of metabolites such as alkaloids, flavonoids, sugars, vitamins, amino acids, phenols,
terpenoids, phenols, etc. Though their biological activities are known, it can be evidently
said that these compounds are somehow directly or indirectly responsible for the possible
anti-metastatic effect on lung and colon cancer cells. However, individual testing of each
identified phytochemical is required to reveal and interpret the actual involvement of these
S. repanda compounds in anti-metastasis.
Plants in the genus Selaginella have diverse therapeutic potential on different cancer
cells, comprising induction of apoptosis, inhibition of cell proliferation and arrest of cell
cycle. There are species of Selaginella (S. delicatula, S. tamariscina, S. moellendorffii), which
are known to possess potent antioxidant and antitumor activities, related to activation
of apoptosis through DNA fragmentation and nucleus clotting [36], by inducing the
expression of p53 and G1 arrest [37], through obstruction in fatty acid synthesis [38],
inhibiting transactivation of iNOS and COX-2 via inactivating the NF-kB and avoiding the
p65 translocation [39]. Several studies revealed the potent antitumor activities by S. uncinata
and S. tamariscina, while moderate activity was found against Bel-7402 and HeLa cells by
S. moellendorfii. Furthermore, out of all Selaginella species in the world, S. tamariscina is
considered one of the most biologically potent plants, which is very well-known to inhibit
the growth of various cancers (breast, leukemia, gastric, lung) [36–39]. Additionally, in
osteosarcoma cells, it also possesses the anti-metastatic activity by down-regulating the
MMP-2 and MMP-9 secretions and increasing the TIMP-1 and TIMP-2 expressions via
Akt-dependent and p38 pathways [37,38,40–42].
A similar study with S. delicatula revealed the cytotoxicity against cancer cells of
P-388, HT-29 [43] Raji, Calu-1, lymphoma and leukemia [44], due to the presence of
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phytocompounds robustaflavone and amentoflavone or its derivatives. Few other studies
using S. moellendorfii show the growth inhibition of OVCAR-3, HeLa and FS-5 cancer
cells [45,46], and anti-metastasis activity in lung cancer cells [39]. However, no studies on
cytotoxicity and anti-metastasis of S. repanda crude extract against human cancer cells exist
to date, and the mechanism of anticancer potential also remains unclear. Therefore, our
study was designed to potentially identify the anti-metastatic activity of S. repanda crude
extract against A549 and HCT-116 cancer cells with a possible molecular mechanism.
S. repanda crude extract displayed significant cytotoxic potential on both malignant
A549 and HCT-116 cancer cells, and their IC50 were 341.1 µg/mL and 378.8 µg/mL, respec-
tively. We performed an in vitro wound healing assay to evaluate the effect of S. repanda
crude extract on cell migration, as migration is an important event in the progression
of metastasis and cancer. S. repanda crude extract significantly inhibited the migration
of cancer cells in the direction of the wounded area. Such results of the present study
displayed that S. repanda crude extract impeded cell migration, which is crucial during
the early phase of wound healing. Furthermore, S. repanda crude extract also remarkably
retarded the invasion of both malignant cancer cells. Therefore, in the present study using
wound healing, adhesion and invasion assays, we have shown that S. repanda crude extract
efficiently inhibits the metastasis in both malignant cells in vitro.
To further elucidate the possible molecular mechanism behind the anti-metastatic
potential of S. repanda crude extract, the mRNA expression level of MMP-2 and MMP-9
genes involved in the metastasis process was investigated. Both MMP-2 and MMP-9 genes
mRNA expression levels were significantly decreased in a dose-dependent manner in both
malignant cells. In metastasis, MMP-9 is considered the most significant protease, and its
expression is connected with the growth of local tumor, invasion and metastasis in the
majority of the carcinomas [47]. Therefore, increasing evidence suggests that a particular
suppression of MMP-9 activity might avert metastasis [48]. Moreover, the expression of
MMP genes is mainly controlled by their activators and inhibitors at the transcriptional,
post-transcriptional and at the protein level [26,49]. TIMPs are assumed to play an immense
role in the inhibition of MMPs [50]. In the present study, A549 and HCT-116 cells treated
with S. repanda crude extract collectively up-regulated the expression of TIMP-1 gene. Apart
from TIMP-1, MT1-MMP is another key enzyme among the regulation of MMPs, whose
overexpression has the main effect on the growth of tumors [51]. It is mainly responsible
for the activation of MMP2 [52,53]. The expression of MT1-MMP gene was significantly
found to be inhibited in both A549 and HCT-116 cells treated with S. repanda crude extract.
Hence, these results revealed that anti-metastatic effect of S. repanda crude extract is linked
to the inhibition of enzymatically degradative processes of tumor metastasis.
Natural products are produced by all organisms, but plants are the major contributors.
All of these organisms co-exist in the ecosystem and interact with each other in various ways
in which chemistry plays a major role. Various approaches to understand the taxonomy of
plants have been evolved over the years, which include morphological, anatomical and
chemotaxonomic classification. However, morphological and anatomical classification
system is considered as traditional approach, whereas, the science of chemotaxonomy or
chemical taxonomy is a modern approach to classify the plants, especially on the basis of
their chemical constituents [54,55]. The phenolics, alkaloids, terpenoids and non-protein
amino acids are the four important and widely exploited groups of compounds utilized for
chemotaxonomic classification [56]. These groups of compounds exhibit a wide variation
in chemical diversity, distribution and function [56,57]. From this study, S. repanda have
been recognized as an excellent source of phytoconstituents with diverse chemical class,
hence our data can also be used by ethnopharmacologists, taxonomists and ethnobotanists
for chemotaxonomic importance to solve the selected taxonomical problems.
Furthermore, as we stated earlier that our study is the first study to report the
phytochemistry of S. repanda and the identified constituents can be seen in Table 1. In
the literature, around 130 chemically defined natural products are reported from 32
species of Selaginella, which are belonging to the classes of pigments, benzenoids, al-
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kaloids, carbohydrates, coumarins, flavonoids, chromones, oxygen heterocycle, lignans,
phenylpropanoids, quinoids and steroids. Here, we have discussed the phytoconstituents
of other Selaginella species in comparison to S. repanda. Chao et al. 1987 identified
hordenine, hordenine-[6-O-(4-hydroxy-cinnamoyl)-β-D-glucosyl]-(1,3)-α-L-rhamnoside,
hordenine-O-α-L-rhamnopyranoside, -methyltyramine-O-α-L-rhamnoside as alkaloids in
S. doederleinii [58]. Similarly, in S. moellendorfii, identified alkaloids were selaginellic acid, 5-
hydroxyselaginellic acid, 5-hydroxy-N8,N8-dimethylpseudophrynaminol, N-selaginelloyl-
L-phenylalanine, N-(5-hydroxyselaginelloyl)-L-phenylalanine, neoselaginellic acid, and
N-(5-Hydroxyneoselaginelloyl)-L-phenylalanine [59]. In S. tamariscina, adenosine and
guanosine were identified as alkaloids [60]. Likewise, 4-hydroxy-benzoic acid [61], ar-
butin, vanillic acid, syringic acid [60,62] are identified as benzoids in S. pulvinata and
S. tamariscina respectively.
Additionally, in carbohydrate class, selaginose was identified in S. adunca, S. asperula,
S. epirrhizos, S. galeotti, S. geniculata, S. kraussiana, S. marginata, S. parkeri, S. plumosa, S. san-
guinolenta, S. stellate and S. sulcata [63]; 2-carboxy-arabinitol was identified in S. merten-
sii [64]; and mycose was identified in S. pulvinata [61]. Moreover, 8-methyl-eugenitol,
uncinoside A, uncinoside B was identified as chromone in S. uncinata [65,66]. On the
other hand, numerous flavonoids were identified in various Selaginella species. For exam-
ple, 2,3-dihydroamentoflavone, 2”,3”-dihydroamentoflavone, tetrahydro-amentoflavone
was found in S. bryopteris [67]; amentoflavone-7,4,7,4-tetramethylether was found in
S. moellendorfii [68]; 4′,7”-di-O-methyl-amentoflavone was found in S. sinensis [69]; 4′,7”-
di-O-methyl-amentoflavone was found in S. willdenowii [70]; amentoflavone was iden-
tified in various species of Selaginella i.e., S. braunii, S. davidii, S. delicatula, S. denticu-
lata, S. kraussiana, S. moellendorfii, S. pulvinata, S. rupestris, S. sanguinolenta, S. selaginoides,
S. sinensis, S. stauntoniana, S. tamariscina, S. uncinata, S. willdenowii [44,69–75]; apigenin-7-
O-β-neohesperidoside, apigenin-8-C- β-D-glucopyranoside, 6,8-di-C-β-D-glucopyranosyl-
apigenin, 6-C-β-D-glucopyranosyl-8-C-β-D-xylopyranosyl-apigenin, 6-C-β-D-xylopyranosyl-
8-C-β-D-glucopyranosyl-apigenin was identified in S. moellendorfii [76,77]; 2”,3”-dihydro-
4′,7,7”-trimethylether-robustaflavone, 2,3-dihydro-4′,7,7”-trimethylether-robustaflavone,
2”,3”-dihydro-4′,7,-dimethylether-robustaflavone, 4′,7-dimethylether-robustaflavone, 4′-
methylether-robustaflavone was identified in S. delicatula [44,78]; and sumaflavone was
identified in S. tamariscina [79].
Lignan was also found in other Selaginella species. 5-acethyl-dihydro-2-(3′,5′-dimethoxy-
4′-hydroxy-phenyl)-7-methoxybenzofuran was found in S. tamariscina [60]; (-)-lirioresinol A,
(-)-lirioresinol B, (+)-matairesinol was found in S. doederleinii [18]; syringaresinol, tamarisci-
noside B, tamariscinoside C was found in S. tamariscina [60,62]. Some important pigments
are also known to be found in various Selaginella species, i.e., selaginellin in S. sinensis [80],
selaginellin A, selaginellin B in S. tamariscina [81], selaginellin C, selaginellin D, selaginellin
E, selaginellin F, selaginellin G, selaginellin H in S. pulvinata [82–84]. Quinoids are also
known to be found in some Selaginella species. Chrysophanic acid, emodin, physcion
are identified in S. stauntoniana [85]; 1-methoxy-3-methylanthraquinone was identified
in S. tamariscina [85]. Similarly, steroids are also known to be present in numerous Se-
laginella species, i.e., cholesterol, 22-dehydrocampesterol in S. delicatula, S. doederleinii [86],
3β-16α-dihydroxy-(5α)-cholestan-21-oic acid in S. pulvinata [87], 24α-ethyl-cholest-5-en-
3β-ol, 24α-methyl-cholest-5-en-3β-ol, 24β-methyl-cholest-5-en-3β-ol, 24α-ethyl-cholesta-
5,22-dien-3β-ol in S. delicatula and S. doederleinii [86] and β-sitostero in S. doederleinii, S.
moellendorfii and S. pulvinata [61,88,89]. Therefore, our results can also be correlated and
compared with the possibility to identify other Selaginella species for their anti-metastatic
and anticancer efficacy against various carcinomas, due to the presence of diverse and
potential phytoconstituents.
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4. Materials and Methods
4.1. Plant Material Collection and Extraction
Whole plant of S. repanda was collected from the wild regions of Gujarat state, India
during the July–August period of 2019. The voucher specimen (BVBRC035) was deposited
at Bapalal Vaidya Botanical Garden, Department of Biosciences, Veer Narmad South Gujarat
University, Surat, Gujarat, India. The collected plant material was dried in an oven and
then grounded into fine powder followed by storage in airtight containers. A total of 20 g
of S. repanda powder was soaked in 85% ethanol for 24 h at 37 ◦C with vigorous shaking.
The ethanol phase was filtered with Whatman no. 1 filter paper and then concentrated
using a rotary evaporator to get the dried residue. All the assays were performed using a
stock solution of crude ethanol extract.
4.2. HR-LC–MS Analysis
Phytochemistry of S. repanda crude extract was analyzed using UHPLC-PDA-Detector
Mass Spectrophotometer (HR-L = CMS 1290 Infinity UHPLC System), Agilent Technologies®,
Santa Clara, CA, USA. The liquid chromatographic system consisted of the HiP sampler,
binary gradient solvent pump, column compartment and quadrupole time of flight mass
spectrometer (MS Q-TOF) with the dual Agilent Jet Stream Electrospray (AJS ES) ion source.
Of the sample, 10 µL was injected into the system, followed by separation in the SB-C18
column (2.1 mm × 50 mm, 1.8 µm particle size). Solvent A (1% formic acid in deionized
water) and solvent B (acetonitrile) were used as solvents. A flow rate of 0.350 mL/min was
used, while MS detection was performed in MS Q-TOF. Compounds were identified via
their mass spectra and their unique mass fragmentation patterns. Compound Discoverer
2.1, ChemSpider and PubChem were used as the main tools for the identification of the
phytochemical constituents [9].
4.3. Cell culture and Treatment
Human lung (A549) and colon (HCT-116) cancer cell lines were obtained from National
Centre for Cell Science (NCCS), India and propagated in a humidified atmosphere with 5%
CO2 at 37 ◦C. Cells were maintained in 25 cm2 flask having Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS). They were grown up
to 80% confluence for future analyses. Cells were treated with different concentrations of
S. repanda crude extract (100–500 µg/mL).
4.4. Cell Viability Analysis Using MTT Assay
To determine the cytotoxicity of S. repanda crude extract, an MTT colorimetric assay
was performed. For seeding, 96-well plates were used for both human cancer cell lines
with incubation in humidified atmosphere comprising of 5% CO2 at 37 ◦C up to adherence.
Different concentrations of S. repanda crude extract (100–500 µg/mL) were then used to
treat the cells for 24 h, followed by washing with PBS solution. Cells were then subjected
with 100 µL of MTT solution (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide)
(5 mg/mL), followed by 4-h incubation. The medium was then removed and to solubilize
the formazan crystals, 100 µL of dimethyl sulfoxide (DMSO) was added. Using ELISA
reader, the amount of formazan crystal was determined by measuring the absorbance at
570 nm. All assays were carried out in triplicate, and 50% cytotoxic concentration (IC50)
was calculated. 5-Fluorouracil was used as a positive control.
4.5. Wound Closure Assay
The effect of S. repanda crude extract on the motility of A-549 and HCT-116 cells was
carried out using the wound healing assay. Confluent monolayer cell culture grown in
6 well plates was used to perform the assay. Cells were seeded at 1 × 106 cells/mL in
3 mL final volume of growth medium. With the help of a sterile 1 mL pipette tip, an
injury line was made in the central area of culture. After washing with phosphate-buffered
saline (PBS), DMEM medium containing 2% FBS with and without S. repanda crude extract
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(100–500 µg/mL) was added into the well, floating cells were discarded. Plates were then
incubated for 48 h at 37 ◦C. Wound closure through cell migration was measured at 0,
24 and 48 h under a microscope. The cells migration towards the wound scratches was
expressed as migrated cells percentage and calculated as [90]:
Migrated cells percentage = [(At = 0 h − At = ∆h)/At = 0 h] × 100 (1)
where,
At = 0 h is the area of wound measured immediately after scratching
At = ∆h is the area of wound measured 24 or 48 h after scratching
4.6. Invasion Assay
The effect of S. repanda crude extract on the invasion ability of A549 and HCT-116 cells
were observed using Transwell® chambers with 6.5 mm polycarbonate filters of 8 µm pore
size (TCP152, Himedia®, India). A 50 µL aliquot of the Matrigel (E1270, Merck®, India) was
pipetted into the upper chamber (culture insert), which was placed in a lower chamber with
sterile forceps and incubated for the solidification of the gel at 37 ◦C for 30 min. Cells were
seeded into the upper chamber with 1 × 106 cells/mL consisting of 100 µL of serum free
media. Immediately this chamber was then transferred into the lower chamber consisting
of 600 µL of medium (2% FBS) with and without S. repanda crude extract (100–500 µg/mL).
The plates were then incubated for 24 h at 37 ◦C. Afterward, the upper chamber was taken
out, and using the cotton buds, non-migrated cells on its inner surface were wiped off.
Furthermore, the migrated cells on the outer surface of the upper chamber were fixed
using 70% methanol for 10 min. It was then followed by staining with 0.2% crystal violet,
washing with distilled water and air drying at room temperature [91]. Under an inverted
microscope, invaded cells were then observed. The cells invasion through the permeable
matrix gel was expressed as percentage of invading cells and calculated as:
% invading cells = [Mean number of cells invading through the permeable matrix
gel/Mean number of cells migrating through uncoated culture insert] × 100 (2)
Mean number of cells migrating through uncoated culture insert.
4.7. Cell Adhesion Assay
The effect of S. repanda crude extract on the adhesion ability of A549 and HCT-116 cells
was carried out according to the method described previously by Burg–Roderfeld et al.,
(2007) [92]. Firstly, 0.1% gelatin was coated on the surface of the 6 well culture plates and
left to air dry at 37 ◦C for 30 min. Both A549 and HCT-116 cells (1 × 106 cells/mL) were
harvested by trypsin and resuspended in a medium with and without S. repanda crude extract
(100–500 µg/mL). Then, cells were dispensed into the respective wells and further incubated
at 37 ◦C for 2, 4 and 6 h in 5% CO2. At the end of incubation, attached cells were gently
washed with PBS twice and counted time dependently under an inverted microscope.
4.8. Expression Levels Determination of Metastasis Related Genes
Using the TriPure Isolation Reagent (Sigma-Aldrich®, India) and according to the man-
ufacturer’s instructions, cellular RNA was isolated. RNA was quantified electrophoretically
using 1.2% agarose gel, staining with ethidium bromide and visualizing under UV light.
Firstly, RT-first strand synthesis kit (Qiagen®, CA, USA) was used to reverse transcribe
the 1 µg of isolated RNA, and then the relative expression of metastasis related genes
was determined by SYBR green based qRT PCR method (Applied Biosystems® 7500 Fast
Real-Time PCR machine, CA, USA). ∆∆Ct method was then followed to analyze the data,
and values were expressed in terms of fold change relative to control [93,94]. Cycling
conditions for relative expression of genes were as follows: initial reverse transcription at
55 ◦C for 45 min, 1 cycle denaturation of 95 ◦C with 10 min hold, followed by 40 cycles
of 95 ◦C with 15 s hold, annealing temperature at 60 ◦C (MMP-2, MMP-9, MT1-MMP,
TIMP-1 and GAPDH) with a 60 s hold. Four pairs of primers were separately used (Table 2).
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Samples were run in triplicate and their relative expression was determined by normalizing
the expression of each target GAPDH.
Table 2. List of primers used for metastasis related genes [95].





















All the results are expressed as mean ± SD of the number of experiments performed.
A significance test was carried out among the treatments by one way ANOVA followed by
Tukey’s post hoc test at p < 0.05. Statistical analysis was conducted with software GraphPad
Prism 5.0.
5. Conclusions
As per our knowledge, this study is the first one that demonstrates the anti-metastatic
effect of S. repanda crude extract on lung and colon cancer cells. In conclusion, this study
revealed that S. repanda crude extract exerts an inhibitory effect on various crucial steps of
metastasis such as cell adhesion, invasion and migration via modulating the activities of
metastasis related proteases and their activators and inhibitors. This reveals that S. repanda
can be used/recommended as a potential anti-metastatic agent for drug development and
therapy in cancer treatment.
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